Faron Pharmaceuticals Oy (FARN) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Azacitidine, Venetoclax, Bexmarilimab | Acute Myeloid Leukemia, Myelodysplastic Syndromes, Relapsed/Refractory Aml, Chronic Myelomonocytic Leukemia | phase1AndPhase2 | Active Not Recruiting | A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies | Jun 15, 2022 | ― |
| Fp-1305 (Bexmarilimab) | Cancer | phase1AndPhase2 | Completed | A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS) | Oct 23, 2018 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Azacitidine, Venetoclax, Bexmarilimab | phase1AndPhase2 | Acute Myeloid Leukemia, Myelodysplastic Syndromes, Relapsed/Refractory Aml, Chronic Myelomonocytic Leukemia | Active Not Recruiting | A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies | Jun 15, 2022 | ― |
| Fp-1305 (Bexmarilimab) | phase1AndPhase2 | Cancer | Completed | A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS) | Oct 23, 2018 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Faron Pharmaceuticals Oy (GB:FARN) have in its pipeline
Faron Pharmaceuticals Oy GB:FARN is currently developing the following drugs: Azacitidine, Venetoclax, Bexmarilimab, Fp-1305 (Bexmarilimab). These drug candidates are in various stages of clinical development as the company works toward FDA approval.